NIO Inc. NIO has been implementing a comprehensive set of cost-cutting and efficiency-improvement measures to achieve profitability. The company has systematically reviewed all projects and ...

Vincerx Pharma (VINC) announced plans to implement cost-controls and explore strategic alternatives to support advancing the Phase 1 study of VIP943, the company’s novel CD123-targeted antibody-drug ...

CEO Joel Anderson highlighted that 2025 marks the 60th anniversary of the Petco brand and noted significant progress in resetting the company's operational model. He emphasized a phased approach to ...

Typical delivery methods consist of contracts based on (a) a lump or stipulated sum, where the parties agree on a fixed price for the entire project or phase; (b) a guaranteed maximum price (GMP), ...

Management maintained its 2025 adjusted EBITDA guidance of $280 million, projecting improved profitability in the RUPS segment and cost reductions in CM&C, despite expected lower volumes in PC.